Briefs: Granules India
Drug Approval

Briefs: Granules India

Granules India received approval from Brazilian Health Regulatory Agency ANVISA

  • By IPP Bureau | August 28, 2023

Granules India received Accreditation Certificate of Foreign Drug Manufacturer from PMDA

Granules India Limited has received the Accreditation Certificate of Foreign Drug Manufacturer from Pharmaceuticals and Medical Devices Agency (PMDA), Japan for its Jeedimetla facility, located at Jeedimetla, Quthbullapur Mandal, MedchalMalkajgiri District, Hyderabad, Telangana.

The certification has been received for accreditation categories of non-sterile Drugs, Packaging, Labelling and Storage of Drugs.

Jeedimetla facility manufactures Active Pharmaceutical Ingredients (API) and Pharmaceutical Formulation Intermediates (PFIs).

Granules India received approval from Brazilian Health Regulatory Agency ANVISA

Granules India Limited has received the approval from Brazilian Health Regulatory Agency (ANVISA), for compliance with the guidelines of Good Manufacturing Practices for its Bonthapally facility, located at Bonthapally Village, Gummadidala Mandal, Sangareddy District, Hyderabad, Telangana. Bonthapally facility manufactures Active Pharmaceutical Ingredients (API).

Upcoming E-conference

Other Related stories

Startup

Digitization